Hormonal contraceptives and hair dyes increase breast cancer risk

March 9, 2017, University of Helsinki

In her recent doctoral dissertation, researcher Sanna Heikkinen from the University of Helsinki and Finnish Cancer Registry evaluates the contribution of the use of hormonal contraceptives and hair dyes to the spectrum of breast cancer risk factors.

The analysis included self-reported survey data from 8000 breast cancer patients and 20 000 controls from Finland.

According to the results, use of hormonal intrauterine device was associated with 52% increased risk of breast cancer in post-menopausal women, when compared to women who had used copper intrauterine device.

The use of other hormonal contraceptives was, by contrast, associated with 32% higher among younger women under 50 when compared to women who did not use hormonal contraceptives.

There was also a 23% observed increase in the risk of breast cancer among women who dyed their hair compared to those who didn't.

To confirm the roles of these factors, further research on the effects of , most specifically hormonal intrauterine device, and hair dyes is needed with other populations and a prospective study design.

"The biggest risk factor in is high age, and known lifestyle-related risk factors include late age at first birth, small number of children, high alcohol consumption, and sedentary lifestyle," Heikkinen stresses.

Many of these factors have become significantly more common in Western countries, including Finland, during the last decades.

In her research, Heikkinen also investigated the amount of opportunistic mammography, which was found to be very common. More than 60% of responders reported having had a mammography before the screening age of 50.

"Women should be more extensively informed of the harms of opportunistic mammography, such as accumulating radiation burden and the potential consequences of false positive or negative findings," Heikkinen says.

Explore further: Low thromboembolism risk for contraceptive use in diabetes

Related Stories

Low thromboembolism risk for contraceptive use in diabetes

December 6, 2016
(HealthDay)—For women with diabetes who are using hormonal contraception, the absolute risk of thromboembolism is low, with the lowest rates seen with use of intrauterine and subdermal contraceptives, according to a study ...

Hormonal contraception may raise depression risk

September 29, 2016
(HealthDay)—Women who use hormonal methods for birth control may have a higher risk of developing depression—and teenagers may be most vulnerable, according to a study published online Sept. 28 in JAMA Psychiatry.

False-positive mammography results are common

January 12, 2016
(HealthDay)—For women undergoing digital mammography screening, false-positive results are common, especially among younger women and those with risk factors, according to research published online Jan. 12 in the Annals ...

Potential effects of fertility treatments on breast density and cancer risk

April 13, 2016
Infertility and hormonal fertility treatments may influence the amount of dense tissue in the breast, a risk factor for breast cancer, according to a study involving 43,313 women, published in the open access journal Breast ...

Long-term use of hormonal contraceptives is associated with an increased risk of brain tumors

January 22, 2015
Taking a hormonal contraceptive for at least five years is associated with a possible increase in a young woman's risk of developing a rare tumour, glioma of the brain. This project focussed on women aged 15 -49 years and ...

Obesity is risk factor for rare type of stroke in women using oral contraceptives

March 14, 2016
Obese women who used oral contraceptives appeared to have increased risk for a rare type of stroke known as a cerebral venous thrombosis (CVT) compared with women of normal weight who did not use oral contraceptives, according ...

Recommended for you

Researchers identify a mechanism that fuels cancer cells' growth

November 14, 2018
Scientists at the UCLA Jonsson Comprehensive Cancer Center have identified sodium glucose transporter 2, or SGLT2, as a mechanism that lung cancer cells can utilize to obtain glucose, which is key to their survival and promotes ...

A new approach to detecting cancer earlier from blood tests: study

November 14, 2018
Cancer scientists led by principal investigator Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have combined "liquid biopsy", epigenetic alterations and machine learning to develop a blood test to detect and classify ...

New antibody breakthrough to lead the fight against cancer

November 14, 2018
Scientists at the University of Southampton have developed a new antibody that could hold the key to unlocking cancer's defence against the body's immune system.

Photoacoustic imaging may help doctors detect ovarian tumors earlier

November 14, 2018
Ovarian cancer claims the lives of more than 14,000 in the U.S. each year, ranking fifth among cancer deaths in women. A multidisciplinary team at Washington University in St. Louis has found an innovative way to use sound ...

Solving the mystery of NPM1 in acute myeloid leukemia

November 13, 2018
Although it has long been recognized that mutations of gene NPM1 play an important role in acute myeloid leukemia, no one has determined how the normal and the mutated forms of the protein NPM1 function.

Cognitive decline—radiation—brain tumor prevented by temporarily shutting down immune response

November 13, 2018
Treating brain tumors comes at a steep cost, especially for children. More than half of patients who endure radiation therapy for these tumors experience irreversible cognitive decline, a side-effect that has particularly ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.